MediWound Ltd (MDWD)

Etorro trading 970x250
MediWound Ltd (MDWD) Logo

About MediWound Ltd

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. Address: 42 Hayarkon Street, Yavne, Israel, 8122745

MediWound Ltd News and around…

Latest news about MediWound Ltd (MDWD) common stock and company :

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

MediWound Announces Peer-Reviewed Publication of EscharEx In-Vivo Head-to-Head Comparator Study in the Journal of Wound Care
04 Oct, 2021 Yahoo! Finance

EscharEx Treatment Demonstrated Superior Efficacy in Debridement of EscharYAVNE, Israel, Oct. 04, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, today announced a peer-reviewed publication in the Journal of Wound Care of an in vivo head-to-head study comparing EscharEx® and a commercial enzymatic debridement agent in the removal of chronic wound eschar. T

MediWound to Present at Upcoming Investor Conferences
03 Sep, 2021 FinancialContent
MediWound Ltd. (NASDAQ:MDWD) Just Reported And Analysts Have Been Cutting Their Estimates
12 Aug, 2021 Yahoo! Finance

Last week, you might have seen that MediWound Ltd. ( NASDAQ:MDWD ) released its second-quarter result to the market...

MediWound (MDWD) Reports Q2 Loss, Tops Revenue Estimates
10 Aug, 2021 Yahoo! Finance

MediWound (MDWD) delivered earnings and revenue surprises of -9.09% and 6.36%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

MediWound Reports Second Quarter Financial Results
10 Aug, 2021 FinancialContent
Earnings Scheduled For August 10, 2021
10 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its ...

MediWound's Earnings: A Preview
09 Aug, 2021 FinancialContent

On Tuesday, August 10, MediWound (NASDAQ:MDWD) will release its latest earnings report. Benzinga's outlook for MediWound is included in ...

Would Shareholders Who Purchased MediWound's (NASDAQ:MDWD) Stock Five Years Be Happy With The Share price Today?
09 Aug, 2021 Yahoo! Finance

Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results...

MediWound to Report Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 10, 2021
02 Aug, 2021 FinancialContent
Will MediWound (MDWD) Report Negative Q2 Earnings? What You Should Know
29 Jul, 2021 Yahoo! Finance

MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
28 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

MediWound Announces Positive Outcome of Interim Assessment for its EscharEx U.S. Phase 2 Adaptive Design Study
28 Jul, 2021 FinancialContent
MediWound Starts Testing MW005 In Two Mid-Stage Trials In Patients With Non-Melanoma Skin Cancer
26 Jul, 2021 FinancialContent

MediWound Ltd(NASDAQ: MDWD)has initiated a Phase 1/2 studyof MW005 to treat low-risk Basal Cell Carcinoma ...

MediWound Announces Initiation of U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
26 Jul, 2021 FinancialContent
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
25 Jul, 2021 FinancialContent

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism ...

28 Stocks Moving in Wednesday's Pre-Market Session
21 Jul, 2021 FinancialContent

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on ...

MediWound's NexoBrid Shows Significant Beneficial Impact On Pediatric Burn Patients
20 Jul, 2021 FinancialContent

MediWound Ltd(NASDAQ: MDWD)has announced topline resultsfrom Phase 3 pediatric study with NexoBrid to treat severe ...

MediWound Announces Positive Topline Results from Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns
20 Jul, 2021 FinancialContent

Primary Endpoints Met with Highly Statistically Significant Results Compared with Standard-of-Care

Bear of the Day: Vericel (VCEL)
19 Jul, 2021 Yahoo! Finance

Restoring cartilage in sports medicine and rebuilding skin after severe burns gave this small-cap big upside

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediWound Ltd. - MDWD
16 Jul, 2021 FinancialContent
MediWound Announces Peer-Reviewed Paper Detailing EscharEx Phase 2 Randomized Control Trial Results Published in the Online Wound Repair and Regeneration Journal
09 Jul, 2021 FinancialContent
20 Stocks Moving in Thursday's Pre-Market Session
01 Jul, 2021 FinancialContent

Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently ...

58 Biggest Movers From Yesterday
30 Jun, 2021 FinancialContent

Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly ...

Why Vericel Tumbled by Nearly 15% on Tuesday
29 Jun, 2021 Yahoo! Finance

Tuesday was not a good day to be a Vericel (NASDAQ: VCEL) investor. In what must have been a painful admission, Vericel announced Tuesday morning that the biotech's development partner MediWound received what amounts to a rejection letter from the FDA. Formally speaking, this was a complete response letter from the regulator, in which it said it could not approve the biologics license application (BLA) for the two companies' NexoBrid in the BLA's current form.

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of MediWound Ltd. (MDWD) Investigation
29 Jun, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / June 29, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MediWound Ltd. ('MediWound' or 'the Company') (NASDAQ:MDWD).

Mid-Afternoon Market Update: US Stocks Mostly Flat; DiaMedica Therapeutics Shares Plunge
29 Jun, 2021 FinancialContent

Toward the end of trading Tuesday, the Dow traded up 0.04% to 34,295.41 while the NASDAQ rose 0.13% to 14,518.98. The S&P traded ...

Why Shares Of MediWound And Vericel Fell On Tuesday
29 Jun, 2021 FinancialContent

Shares of MediWound (NASDAQ: MDWD) and its development partner, Vericel Corporation (NASDAQ: VCEL), are trading lower after MediWound ...

Mid-Day Market Update: Gold Drops Over 1%; Cerevel Therapeutics Shares Spike Higher
29 Jun, 2021 FinancialContent

Midway through trading Tuesday, the Dow traded up 0.37% to 34,411.60 while the NASDAQ fell 0.03% to 14,495.75. The S&P also rose, ...

35 Stocks Moving In Tuesday's Mid-Day Session
29 Jun, 2021 FinancialContent

Gainers Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) shares jumped 111.5% to $26.58 after the company announced positive ...

MediWound Ltd (MDWD) is a NASDAQ Common Stock listed in , ,

970x250